Table 1.
Peripheral | Left adrenal | Right adrenal | SI Left |
SI Right |
LI L/R ratio |
LI R/L ratio |
|
---|---|---|---|---|---|---|---|
Patient 1 | |||||||
Cortisol [µg/dl] | 6.4 | 28.1 | 27.6 | 4.4 | 4.3 | 1.0 | |
Aldosterone [ng/l] | 78.7 | 342.3 | 241.8 | 4.3 | 3.1 | 1.4 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | 2.6 | 2.9 | 3.1 | 1.1 | 1.2 | 1.1 | |
Androstenedione [ng/ml] | |||||||
Patient 2 | |||||||
Cortisol [µg/dl] | 15.1 | 106 | 35.8 | 7.0 | 2.4 | 3.0 | |
Aldosterone [ng/l] | |||||||
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | <0.1 | <0.1 | 0.2 | 1 | 4 | 11.8 | |
Androstenedione [ng/ml] | |||||||
Patient 3 | |||||||
Cortisol [µg/dl] | 16.8 | 44.3 | 32.8 | 2.6 | 2.0 | 1.4 | |
Aldosterone [ng/l] | <35 | 58.2 | 83.2 | 3.3 | 4.8 | 1.9 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 4 | |||||||
Cortisol [µg/dl] | 22.9 | 127.2 | 125.7 | 5.6 | 5.5 | 1.0 | |
Aldosterone [ng/l] | <35 | 110 | 116 | 6.3 | 6.6 | 1.1 | |
Metanephrine [pg/ml] | <36 | 87 | 365 | 4.8 | 20.3 | 4.2 | |
Normetanephrine [pg/ml] | <48 | 52 | 100 | 2.2 | 4.2 | 1.9 | |
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 5 | |||||||
Cortisol [µg/dl] | 12.9 | 37.7 | 271.9 | 2.9 | 21.1 | 7.2 | |
Aldosterone [ng/l] | <35 | 1720 | 272 | 98.3 | 15.5 | 45.6 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 6 | |||||||
Cortisol [µg/dl] | 10.8 | 512 | 616.8 | 47.4 | 57.1 | 1.2 | |
Aldosterone [ng/l] | |||||||
Metanephrine [pg/ml] | <36 | 5987 | 2288 | 332.6 | 127.1 | 3.2 | |
Normetanephrine [pg/ml] | 66 | 1617 | 568 | 24.5 | 8.6 | 3.4 | |
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 7 | |||||||
Cortisol [µg/dl] | 8.6 | 38.9 | 216.9 | 4.5 | 25.2 | 5.6 | |
Aldosterone [ng/l] | |||||||
Metanephrine [pg/ml] | 40 | 88 | 2105 | 2.2 | 52.6 | 4.3 | |
Normetanephrine [pg/ml] | <48 | <48 | 552 | 1.0 | 23 | 4.1 | |
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 8 | |||||||
Cortisol [µg/dl] | 10.4 | 633.5 | 50.9 | 60.9 | 4.9 | 12.5 | |
Aldosterone [pg/ml] | 239 | 1840 | 2190 | 7.7 | 9.2 | 14.8 | |
Metanephrine [pg/ml] | <36 | 2096 | 1005 | 116.4 | 55.8 | 6 | |
Normetanephrine [pg/ml] | <48 | 601 | 371 | 25 | 15.5 | 7.7 | |
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 9 | |||||||
Cortisol [µg/dl] | 7.8 | 179 | 17 | 22.9 | 2.2 | 10.5 | |
Aldosterone [ng/l] | <35 | 179 | 220 | 10.2 | 12.6 | 12.9 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 10 | |||||||
Cortisol [µg/dl] | 11.7 | 41.3 | 271.7 | 3.5 | 23.2 | 6.6 | |
Aldosterone [pg/ml] | 86 | 140 | 357 | 1.6 | 4.2 | 2.6 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | <0.24 | 9.4 | 24.24 | 78.3 | 202 | 2.6 | |
Patient 11 | |||||||
Cortisol [µg/dl] | 14.5 | 154.8 | 32.4 | 10.7 | 2.2 | 4.8 | |
Aldosterone [pg/ml] | 94 | 1270 | 329 | 13.5 | 3.5 | 1.2 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | 0.66 | 7.94 | 7.25 | 12.0 | 11.0 | 4.4 | |
Patient 12 | |||||||
Cortisol [µg/dl] | 9.0 | 23.7 | 39.7 | 2.6 | 4.4 | 1.7 | |
Aldosterone [pg/ml] | 52 | 239 | 277 | 4.6 | 5.3 | 1.4 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 13 | |||||||
Cortisol [µg/dl] | 10.6 | 35.6 | 22.0 | 3.4 | 2.1 | 1.6 | |
Aldosterone [ng/l] | 37 | 63 | 315 | 1.7 | 8.5 | 8.1 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 14 | |||||||
Cortisol [µg/dl] | 12.4 | 74.3 | 46.9 | 6.0 | 3.8 | 1.6 | |
Aldosterone [ng/l] | 37 | 1415 | 420 | 38.2 | 11.4 | 2.1 | |
Metanephrine [pg/ml] | |||||||
Normetanephrine [pg/ml] | |||||||
DHEA-S [µg/ml] | |||||||
Androstenedione [ng/ml] | |||||||
Patient 15 | |||||||
Cortisol [µg/dl] | 8.5 | 28.8 | 56.5 | 3.4 | 6.6 | 2.0 | |
Aldosterone [ng/l] | 47 | 1008 | >1320 | 21.4 | 28.1 | 1.5 | |
Metanephrine [pg/ml] | <28 | 2410 | 1770 | 172 | 126 | 2.7 | |
Normetanephrine [pg/ml] | 57 | 663 | 503 | 11.6 | 8.8 | 2.6 | |
DHEA-S [µg/ml] | 0.18 | 0.23 | 0.24 | 1.3 | 1.3 | 1.9 | |
Androstenedione [ng/ml] | |||||||
Patient 16 | |||||||
Cortisol [µg/dl] | 16.6 | 48.8 | >75 | 2.9 | 4.5 | 1.5 | |
Aldosterone [ng/l] | <37 | 311 | 667 | 16.8 | 36.1 | 1.4 | |
Metanephrine [pg/ml] | 995 | 47 | 47 | 0.0 | 0.0 | 1.5 | |
Normetanephrine [pg/ml] | 210 | 68 | 40 | 0.3 | 0.2 | 2.6 | |
DHEA-S [µg/ml] | 0.04 | 0.06 | 0.11 | 1.5 | 2.8 | 1.2 | |
Androstenedione [ng/ml] |
Lower limits of quantification: Cortisol 2 µg/dl, Aldosterone: 35 ng/ml, Metanephrine: 36 pg/ml, Normetanephrine: 48 pg/ml, DHEA-S 0.1 µg/ml, Androstenedione 0.24 ng/ml. When the concentration of the measured hormones was below the lower limit of quantification of the assay, half of the lower limit of quantification was used for calculation. Hormone concentrations above the upper limit of quantification were reported as the upper limit of quantification. The LI, which was used for the interpretation of its patient’s AVS, is marked bold. The patients’ 4 AVS was considered as bilateral, because the lateralization indices adjusted for aldosterone and normetanephrines were 1.9 and 1.1 (despite the lateralization index adjusted for metanephrines of 4.2)
SI Selectivity index, LI Lateralization index, L Left, R Right